Discontinued — last reported Q1 '25
Ingersoll Rand Impairment Charges decreased by 100.0% to $0.00 in Q3 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Frequent or large impairment charges signal poor capital allocation or overly optimistic historical valuations of assets.
Impairment charges represent the write-down of the carrying value of assets when their fair value falls below their book...
Common in cyclical industries where asset values are highly sensitive to external market price assumptions.
impairment_charges| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $36.10M | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |
| Segment | Q2 '25 |
|---|---|
| Precision and Science Technologies | $36.10M |
| Total | $36.10M |
Precision and Science Technologies was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.